Concepedia

Özge Alper

ÖA

Statistics

Publications

8

Citations

364

H-Index

8

Active since

1990

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Georgetown University

National Institute of Neurological Disorders and Stroke

Boston Children's Hospital

Özge Alper is an author at National Institutes of Health specializing in oncology, molecular oncology, and cell biology.

ORCID

Publications per year

1990–2009

8

Publications

8

Epidermal Growth Factor Receptor Signaling and the Invasive Phenotype of Ovarian Carcinoma Cells

Özge Alper, Elke S. Bergmann‐Leitner, Teresa Bennett et al. · JNCI Journal of the National Cancer Institute · 2001 · 144 citations

, , +17

Novel anti‐filamin‐A antibody detects a secreted variant of filamin‐A in plasma from patients with breast carcinoma and high‐grade astrocytoma

Özge Alper, William G. Stetler‐Stevenson, Lyndsay N. Harris et al. · Cancer Science · 2009 · 47 citations · Full text

, , +17

Protein kinase A-Iα subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway

Özge Alper, Neville F. Hacker, Yoon S. Cho‐Chung · Oncogene · 1999 · 33 citations

, , +16

Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line

Svetlana Pack, Özgül M. Alper, Kurt Stromberg et al. · Cancer Research · 2004 · 32 citations

, , +17

Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: Protein kinase A downregulation and cytoplasmic export of CRE-binding proteins

Özge Alper, Elke S. Bergmann‐Leitner, Scott I. Abrams et al. · Molecular and Cellular Biochemistry · 2001 · 31 citations

, , +17

1–5 of 8